482
Participants
Start Date
November 30, 2010
Primary Completion Date
January 31, 2012
Study Completion Date
October 31, 2014
FTC/RPV/TDF
Emtricitabine (FTC) 200 mg/rilpivirine (RPV) 25 mg/tenofovir disoproxil fumarate (tenofovir DF; TDF) 300 mg single-tablet regimen (STR) administered orally with a meal once daily (QD)
PI
Protease inhibitors (PIs) included amprenavir, atazanavir, darunavir, fosamprenavir, Kaletra (lopinavir/ritonavir, coformulated), ritonavir, and saquinavir. PIs were administered according to prescribing information.
RTV
Ritonavir (RTV) was administered according to prescribing information.
NRTIs
NRTIs included abacavir, emtricitabine, Combivir (lamivudine/zidovudine, coformulated), Epzicom (abacavir/lamivudine, coformulated), lamivudine, stavudine, tenofovir DF, Truvada® (emtricitabine/tenofovir DF, coformulated), and zidovudine. NRTIs were administered according to prescribing information.
CHU Saint-Pierre University Hospital, Brussels
Universitaire Ziekenhuis Gent, Ghent
Beth Israel Medical Center, New York
The Aaron Diamond AIDS Research Center, New York
EPIMED GmbH, Berlin
University of Pennsylvania, Philadelphia
Philadelphia FIGHT, Philadelphia
Capital Medical Associates PC, Washington D.C.
Fondazione Centro San Raffaele del Monte Tabor, Milan
Azienda Ospedaliera San Paolo, Mallattie Infettive e Tropicali, Milan
ICH Study Center Hamburg, Hamburg
"National Institute for Infectious Diseases L. Spallanzani IRCCS", Rome
Azienda Ospedaliera Luigi Sacco 1° Divisione Malattie Infettive, Milan
Johns Hopkins University School of Medicine, Lutherville
Clinical Alliance for Research & Education-Infectious Diseases, LLC (CARE-ID), Annandale
Ospedali Riuniti, Bergamo
Wake Forest University Health Sciences, Winston-Salem
Hospital General Universitario Gregorio Marañon, Madrid
Hospital Ramon y Cajal, Madrid
Hospital Clinic i Provincial, Barcelona
Rosedale Infectious Diseases, Huntersville
ID Consultant, P.A., Charlotte
Hospital Germans Trias i Pujol, Barcelona
University of South Carolina, Columbia
Infectious Disease Specialists of Atlanta (IDSA), Decatur
AIDS Research Consortium of Atlanta, Atlanta
Atlanta ID Group, Atlanta
Wade, Barbara Private Practice, Pensacola
Orlando Immunology Center, Orlando
ValueHealthMD, LLC/IDOCF, Orlando
University of South Florida - HIV Clinical Research Unit, Tampa
The Kinder Medical Group, Miami
Wohlfeiler, Piperato and Associates, LLC, Miami Beach
Gary Richmond, MD, PA, Inc., Fort Lauderdale
St. Joseph's Comprehensive Research Institute, Tampa
Barry M. Rodwick, M.D., Safety Harbor
Midway Immunology & Research Center, Ft. Pierce
University of Alabama - Birmingham, Birmingham
Be Well Medical Center, Berkley
University of Cologne, Department of Internal Medicine, Cologne
University of Bonn, Dep. of Internal Medicine I, HIV-Outpatient Clinic, Bonn
Hennepin County Medical Center, Minneapolis
Infectio Research, Frankfurt
Northwestern University Feinberg School of Medicine, Chicago
The Ruth M. Rothstein CORE Center, Chicago
Northstar Medical Center, Chicago
Southampton Healthcare, Inc., St Louis
Hôpital Hôtel-Dieu, Lyon
Health for Life Clinic, PLLC, Little Rock
Department of Infectious Diseases, Saint-Louis hospital, Paris
Hôpital Saint Antoine, Servuce de Maladies Infectieuses, Paris
Bichat Hospital, Paris
Nicholaos Bellos, MD, PA, Dallas
DCOL Center for Clinical Research, Longview
Tarrant County Infectious Diseases Associates, Fort Worth
Therapeutic Concepts, P.A., Houston
Gordon E. Crofoot, MD, PA, Houston
Research Access Network, Houston
Garcia Family Medical Clinic, Harlingen
Spectrum Medical Group, Phoenix
Peter J. Ruane, MD, Inc., Los Angeles
Kaiser Permanente, Los Angeles
Jeffrey Goodman Special Care Clinic, Los Angeles
Oasis Clinic, Los Angeles
Anthony Mills, MD Internal Medicine, Los Angeles
AIDS Healthcare Foundation-Research Center, Beverly Hills
The Living Hope Foundation, Long Beach
La Playa Medical Group and Clinical Research, San Diego
Center for Special Immunology, Costa Mesa
Orange Coast Medical Group, Newport Beach
Metropolis Medical, San Francisco
Kaiser Permanente, San Francisco
Stanford University, Palo Alto
Kaiser Permanente, Hayward
Alameda County Medical Center, Oakland
East Bay AIDS Center, Oakland
University of California, Davis, Sacramento
Kaiser Permanente, Sacramento
Pacific Oaks Medical Group, Beverly Hills
Care Resource, Miami
Kansas City Free Health Clinic, Kansas City
Greiger Clinic, Mount Vernon
Univ.-Kklinik fuer Innere Medizin III, Salzberg
LKH Graz West, Styria
2.Interne Lungenabteilung Otto Wagner Spital, Vienna
Dept. of Dermatology, Div. of Immunology,, Vienna
Private Office, Vienna
University Hospitals Leuven, Flemish Brabant
Downtown Infectious Disease Clinic - Univ of BC, Vancouver
Maple Leaf Research, Toronto
Sunnybrook Health Sciences Centre, Toronto
Winnipeg Regional Health Authority, Winnipeg
Infectiologie - 7ème Ouest - CHU HOTEL DIEU, Nantes
Hopital Tenon, Paris
Maladies Infectieuses Dpt, Paris
Hôpital Haut Levêque, Pessac
Center for HIV and Hepatogastroenterology, Düsseldorf
University Medical Center Hamburg - Eppendorf, Hamburg
Homerton Unversity Hospital, London
Brigham & Women's Hospital, Boston
The Research Institute, Springfield
Saint Michael's Medical Center, Newark
South Jersey Infectious Disease, Somer Point
Clinique Medicale Du Quartier Latin, Montreal
Archet 1 CHU de Nice - 6ème Niveau - Infectiology, Nice
Clinical Research Puerto Rico, Inc., San Juan
Brighton and Sussex University Hospitals NHS Trust, Brighton
Barts and the London NHS Trust, London
Royal Free Hospital, London
Chelsea and Westminster Hospital Foundation Trust, London
North Manchester General Hospital, Manchester
Lead Sponsor
Gilead Sciences
INDUSTRY